EV/EBITDA:
-8.13+0.24(+2.87%)Summary
- As of today, TSHA EV/EBITDA is -8.13, with a rise of +0.24 (+2.87%) during the most recent trading session on November 7, 2025.
- Over the past year, TSHA EV/EBITDA has dropped by -5.72 (-237.34%).
- TSHA EV/EBITDA is now -7290.91% below its all-time high of -0.11.
Performance
TSHA EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
TSHA EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise ValueEnterprise Value | PricePrice |
|---|---|---|---|
| 1D1 Day | +2.9% | -2.9% | -2.3% |
| 1M1 Month | +22.9% | -22.9% | -18.9% |
| 3M3 Months | -39.5% | +59.9% | +36.3% |
| 6M6 Months | -100.7% | +145.3% | +101.6% |
| YTDYTD | -148.6% | +194.2% | +121.4% |
| 1Y1 Year | -237.3% | +320.0% | +169.7% |
| 5Y5 Years | +64.3% | +65.7% | -81.3% |
TSHA EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs Highvs High | LowLow | Current vs Lowvs Low | |
|---|---|---|---|---|---|
| 1M | 1-Month | -8.13 | at high | -12.22 | +33.5% |
| 3M | 3-Month | -5.55 | -46.5% | -12.22 | +33.5% |
| 6M | 6-Month | -4.05 | -100.7% | -12.22 | +33.5% |
| 1Y | 1-Year | -2.14 | -279.9% | -12.22 | +33.5% |
| 3Y | 3-Year | -0.11 | -7290.9% | -12.22 | +33.5% |
| 5Y | 5-Year | -0.11 | -7290.9% | -26.47 | +69.3% |
| All-Time | All-Time | -0.11 | -7290.9% | -26.47 | +69.3% |
TSHA EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -8.13(-148.6%) |
| 2024 | -3.27(+8.4%) |
| 2023 | -3.57(-275.8%) |
| Date | Value |
|---|---|
| 2022 | -0.95(+54.8%) |
| 2021 | -2.10(+89.1%) |
| 2020 | -19.26 |
FAQ
- What is Taysha Gene Therapies, Inc. EV/EBITDA?
- What is the all-time high EV/EBITDA for Taysha Gene Therapies, Inc.?
- What is TSHA EV/EBITDA year-to-date change?
- What is Taysha Gene Therapies, Inc. EV/EBITDA year-on-year change?
What is Taysha Gene Therapies, Inc. EV/EBITDA?
The current EV/EBITDA of TSHA is -8.13
What is the all-time high EV/EBITDA for Taysha Gene Therapies, Inc.?
Taysha Gene Therapies, Inc. all-time high EV/EBITDA is -0.11
What is TSHA EV/EBITDA year-to-date change?
Taysha Gene Therapies, Inc. EV/EBITDA has changed by -4.86 (-148.62%) since the beginning of the year
What is Taysha Gene Therapies, Inc. EV/EBITDA year-on-year change?
Over the past year, TSHA EV/EBITDA has changed by -5.72 (-237.34%)